ReviewCirculation research2018

Cardiovascular Effects of New Oral Glucose-Lowering Agents: DPP-4 and SGLT-2 Inhibitors.

André J ScheenPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.